Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence (Q33685303)

28 July 2017

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence (English)

1 reference

28 July 2017

1 reference

1 reference

D Hawksworth

1

1 reference

28 July 2017

L Ravindranath

2

1 reference

28 July 2017

Y Chen

3

1 reference

28 July 2017

B Furusato

4

1 reference

28 July 2017

I A Sesterhenn

5

1 reference

28 July 2017

D G McLeod

6

1 reference

28 July 2017

S Srivastava

7

1 reference

28 July 2017

G Petrovics

8

1 reference

28 July 2017

7 September 2010

1 reference

Prostate Cancer and Prostatic Diseases

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

4

1 reference

28 July 2017

311-315

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2010.31

28 July 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Targeting the oncogene and kinome chaperone CDC37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Molecular markers of prostate cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Myc goes global: new tricks for an old oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Facilitating replication under stress: an oncogenic function of MYC?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

htert expression correlates with MYC over-expression in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Quantitative expression profile of PSGR in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Recurrent gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2010.31

31 March 2020

Identifiers

DOI

10.1038/PCAN.2010.31

1 reference

28 July 2017

1 reference